Relay Therapeutics, Inc. (RLAY)

8.99 +0.29 (+3.33%) USD  |  NASDAQ  |  Feb 23, 09:39
More

Relay Therapeutics Ending Cash (Quarterly)

Ending Cash (Quarterly) Chart

View Ending Cash (Quarterly) for RLAY.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Ending Cash (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Ending Cash (Quarterly) Range, Past 5 Years

View Ending Cash (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Ending Cash (Quarterly) Benchmarks

View Ending Cash (Quarterly) Benchmarks
Start Trial
Eli Lilly & Co. Upgrade
Celcuity, Inc. Upgrade
Prelude Therapeutics, Inc. Upgrade
Immunome, Inc. Upgrade
ImmunityBio, Inc. Upgrade